Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization

Hepatocellular carcinoma (HCC) is one of the most commonly diagnosed cancers worldwide. Majority of patients with HCC are diagnosed in the advanced stages of disease and hence they are only suitable for palliative therapy. TACE (transarterial chemoembolization) is the most commonly used treatment fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Saleem, de Souza, Nurun Nisa, Qiao, Wang, Kasai, Meidai, Keem, Low Jee, Shelat, Vishal G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838811/
https://www.ncbi.nlm.nih.gov/pubmed/27143815
http://dx.doi.org/10.1155/2016/6120143
_version_ 1782428037434834944
author Ahmed, Saleem
de Souza, Nurun Nisa
Qiao, Wang
Kasai, Meidai
Keem, Low Jee
Shelat, Vishal G.
author_facet Ahmed, Saleem
de Souza, Nurun Nisa
Qiao, Wang
Kasai, Meidai
Keem, Low Jee
Shelat, Vishal G.
author_sort Ahmed, Saleem
collection PubMed
description Hepatocellular carcinoma (HCC) is one of the most commonly diagnosed cancers worldwide. Majority of patients with HCC are diagnosed in the advanced stages of disease and hence they are only suitable for palliative therapy. TACE (transarterial chemoembolization) is the most commonly used treatment for unresectable HCC. It is however unclear if TACE improves the quality of life (QoL) in patients with HCC. The aim of this review is to evaluate the impact of TACE on QoL of HCC patients.
format Online
Article
Text
id pubmed-4838811
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-48388112016-05-03 Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization Ahmed, Saleem de Souza, Nurun Nisa Qiao, Wang Kasai, Meidai Keem, Low Jee Shelat, Vishal G. HPB Surg Review Article Hepatocellular carcinoma (HCC) is one of the most commonly diagnosed cancers worldwide. Majority of patients with HCC are diagnosed in the advanced stages of disease and hence they are only suitable for palliative therapy. TACE (transarterial chemoembolization) is the most commonly used treatment for unresectable HCC. It is however unclear if TACE improves the quality of life (QoL) in patients with HCC. The aim of this review is to evaluate the impact of TACE on QoL of HCC patients. Hindawi Publishing Corporation 2016 2016-04-07 /pmc/articles/PMC4838811/ /pubmed/27143815 http://dx.doi.org/10.1155/2016/6120143 Text en Copyright © 2016 Saleem Ahmed et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Ahmed, Saleem
de Souza, Nurun Nisa
Qiao, Wang
Kasai, Meidai
Keem, Low Jee
Shelat, Vishal G.
Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
title Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
title_full Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
title_fullStr Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
title_full_unstemmed Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
title_short Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
title_sort quality of life in hepatocellular carcinoma patients treated with transarterial chemoembolization
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838811/
https://www.ncbi.nlm.nih.gov/pubmed/27143815
http://dx.doi.org/10.1155/2016/6120143
work_keys_str_mv AT ahmedsaleem qualityoflifeinhepatocellularcarcinomapatientstreatedwithtransarterialchemoembolization
AT desouzanurunnisa qualityoflifeinhepatocellularcarcinomapatientstreatedwithtransarterialchemoembolization
AT qiaowang qualityoflifeinhepatocellularcarcinomapatientstreatedwithtransarterialchemoembolization
AT kasaimeidai qualityoflifeinhepatocellularcarcinomapatientstreatedwithtransarterialchemoembolization
AT keemlowjee qualityoflifeinhepatocellularcarcinomapatientstreatedwithtransarterialchemoembolization
AT shelatvishalg qualityoflifeinhepatocellularcarcinomapatientstreatedwithtransarterialchemoembolization

Ejemplares similares